JP Morgan Chase
MOLN

JP Morgan Chase’s Molecular Partners MOLN Stock Holding History

JP Morgan Chase’s Portfolio MOLN Stock Details MOLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$4 – 7704
2023
Q4 		$4 Buy
+1
New +$4 ﹤0.01% 7457

Other funds holding MOLN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

JP Morgan Chase's MOLN Position: Q1 2024 in Review

JP Morgan Chase sold out of Molecular Partners (MOLN) in Q1 2024, closing a stake of 1 share — an estimated $4 sold.

JP Morgan Chase first reported a position in MOLN in Q4 2023 and held it in 1 quarter. The position peaked at $4 in Q4 2023. 8 funds tracked by Wall St. Rank hold MOLN as of Q1 2024.

  • JP Morgan Chase reported no remaining Molecular Partners position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 1 Molecular Partners share in Q1 2024, an estimated $4.
  • JP Morgan Chase first reported a position in Molecular Partners in Q4 2023 and held it in 1 quarter.
  • JP Morgan Chase's Molecular Partners position peaked at $4 in Q4 2023.
  • 8 funds tracked by Wall St. Rank held Molecular Partners as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.